Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Galle

Showing results (1-10 of 709) with videos related to

Pageof 71
Sort By:
Kosmicheskaia Biologiia I Aviakosmicheskaia Meditsina|January 1, 1981
[Quantitative evaluation of the clinical manifestations of motion sickness]R R Galle
Scandinavian Journal of Gastroenterology|September 11, 2012
Gastrointestinal disorders and dabigatranArthur Hoffman, P R Galle
Molecular Medicine Today|April 21, 1998
Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implicationsS Strand, P R Galle
Zeitschrift Fur Gastroenterologie|June 30, 2005
[Primary sclerosing cholangitis is a premalignant condition]C Schramm, P R Galle
Current Oncology (Toronto, Ont.)|December 21, 2020
Role of immunotherapy in the management of hepatocellular carcinoma: current standards and future directionsA Weinmann, P R Galle
Seminars in Cancer Biology|August 11, 2000
Apoptosis and the liverS Kanzler, P R Galle
World Journal of Gastroenterology|April 13, 2006
Treatment of nonalcoholic fatty liver diseaseJuergen Siebler, Peter R Galle
Arzneimittel-Forschung|December 1, 1990
Inhibition of hepatitis B virus polymerase-activity by various agents. Transient expression of hepatitis B virus DNA in hepatoma cells as novel system for evaluation of antiviral drugsP R Galle, L Theilmann
European Journal of Gastroenterology & Hepatology|July 28, 2001
Apoptosis in liver diseaseM Schuchmann, P R Galle
Hepatic Oncology|September 8, 2018
The 9th Annual Conference of the International Liver Cancer Association (ILCA) 2015Jens U Marquardt, Peter R Galle
Pageof 71

Showing results (1-10 of 709) with videos related to

Sort By:
Pageof 71
Kosmicheskaia Biologiia I Aviakosmicheskaia Meditsina|January 1, 1981
[Quantitative evaluation of the clinical manifestations of motion sickness]R R Galle
Scandinavian Journal of Gastroenterology|September 11, 2012
Gastrointestinal disorders and dabigatranArthur Hoffman, P R Galle
Molecular Medicine Today|April 21, 1998
Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implicationsS Strand, P R Galle
Zeitschrift Fur Gastroenterologie|June 30, 2005
[Primary sclerosing cholangitis is a premalignant condition]C Schramm, P R Galle
Current Oncology (Toronto, Ont.)|December 21, 2020
Role of immunotherapy in the management of hepatocellular carcinoma: current standards and future directionsA Weinmann, P R Galle
Seminars in Cancer Biology|August 11, 2000
Apoptosis and the liverS Kanzler, P R Galle
World Journal of Gastroenterology|April 13, 2006
Treatment of nonalcoholic fatty liver diseaseJuergen Siebler, Peter R Galle
Arzneimittel-Forschung|December 1, 1990
Inhibition of hepatitis B virus polymerase-activity by various agents. Transient expression of hepatitis B virus DNA in hepatoma cells as novel system for evaluation of antiviral drugsP R Galle, L Theilmann
European Journal of Gastroenterology & Hepatology|July 28, 2001
Apoptosis in liver diseaseM Schuchmann, P R Galle
Hepatic Oncology|September 8, 2018
The 9th Annual Conference of the International Liver Cancer Association (ILCA) 2015Jens U Marquardt, Peter R Galle
Pageof 71